DrugDashboards

AHH Mold Mix

Alternaria alternata, Bipolaris sorokiniana and Cladosporium sphaerospermum · CLADOSPORIUM SPHAEROSPERMUM .0166 g/mL; COCHLIOBOLUS SATIVUS .0166 g/mL; ALTERNARIA ALTERNATA .0166 g/mL · Solution · Intradermal; Percutaneous; Subcutaneous · Greer Laboratories, Inc.

NDC 22840-9621-02 · 10 mL in 1 VIAL, MULTI-DOSE · BLA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 2 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
BLA101833
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Alternaria alternata, Bipolaris sorokiniana and Cladosporium sphaerospermum (Solution)

LabelerStrengthFirst seenLast seen
Greer Laboratories, Inc.CLADOSPORIUM SPHAEROSPERMUM .00033 g/mL; COCHLIOBOLUS SATIVUS .00033 g/mL; ALTERNARIA ALTERNATA .00033 g/mLJul 22, 2026Sep 2, 2026
Greer Laboratories, Inc.CLADOSPORIUM SPHAEROSPERMUM 13333.333 [PNU]/mL; COCHLIOBOLUS SATIVUS 13333.333 [PNU]/mL; ALTERNARIA ALTERNATA 13333.333 [PNU]/mLJul 22, 2026Sep 2, 2026
Greer Laboratories, Inc.CLADOSPORIUM SPHAEROSPERMUM .0166 g/mL; COCHLIOBOLUS SATIVUS .0166 g/mL; ALTERNARIA ALTERNATA .0166 g/mLJul 22, 2026Aug 28, 2026
Greer Laboratories, Inc.ALTERNARIA ALTERNATA .0166 g/mL; CLADOSPORIUM SPHAEROSPERMUM .0166 g/mL; COCHLIOBOLUS SATIVUS .0166 g/mLJul 15, 2026Jul 18, 2026
Greer Laboratories, Inc.ALTERNARIA ALTERNATA .00033 g/mL; CLADOSPORIUM SPHAEROSPERMUM .00033 g/mL; COCHLIOBOLUS SATIVUS .00033 g/mLJul 15, 2026Jul 15, 2026
Greer Laboratories, Inc.ALTERNARIA ALTERNATA 13333.333 [PNU]/mL; CLADOSPORIUM SPHAEROSPERMUM 13333.333 [PNU]/mL; COCHLIOBOLUS SATIVUS 13333.333 [PNU]/mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "AHH Mold Mix — NDC 22840-9621-02," retrieved September 3, 2026, https://drugdashboards.com/drug/22840962102.

Free to cite with attribution — see how the data is put together.